I-MAB (IMAB) Financials

IMAB Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 484.7 million 147.0 million
2023-03-31 593.8 million 155.3 million
2022-12-31 591.3 million 154.6 million
2022-09-30 573.1 million 149.9 million

IMAB Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 ? ?
2023-03-31 -314.4 million 37.4 million
2022-12-31 ? ?
2022-09-30 ? ?

IMAB Net Income

No data available :(

IMAB Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 406.5 million - 6.6 million
2023-03-31 502.8 million - -
2022-12-31 500.6 million - 8.1 million
2022-09-30 485.3 million - -

IMAB Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 11.5 million
2023-03-31 11.1 million
2022-12-31 13.9 million
2022-09-30 13.4 million

IMAB Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 - 8.9 million - -
2023-03-31 5.5 million 11.6 million 58.7 million -
2022-12-31 - - - -
2022-09-30 - - - -

IMAB Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 391403 -
2023-03-31 -257.2 million 4.0 million
2022-12-31 - -
2022-09-30 - -

IMAB

Price: $1.80

52 week price:
1.16
3.88

Earnings Per Share: -3.74 USD

P/E Ratio: -0.46

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 425462

Market Capitalization: 147.7 million

Links: